Valneva announces closing of approximately $102.0 million global offering

Saint- herblain (france), november 3 , 2021 – valneva se (nasdaq: valn; euronext paris: vla) (the “company”), a specialty vaccine company, announced today the closing which occurred on november 2, 2021 of its previously announced global offering to specified categories of investors of an aggregate 5,175,000 new ordinary shares, after full exercise of the overallotment option granted to the underwriters (the “option”), consisting of a public offering of 354,060 american depositary shares (“adss”), each representing two ordinary shares, in the united states at an offering price of $39.42 per ads (the “u.s. offering”), and a concurrent private placement of 4,466,880 ordinary shares in europe (including france) and other countries outside of the united states at the corresponding offering price of €17.00 per ordinary share (the “european private placement”, and, together with the u.s. offering, the “global offering”). aggregate gross proceeds of the global offering, after full exercise of the option and before deducting underwriting commissions and estimated expenses payable by the company, were approximately $102.0 million (€88.0 million).
VALN Ratings Summary
VALN Quant Ranking